Trial Profile
Evaulation of the clinical efficacy and safety of the combined administration of Imidafenacin and Tamsulosin in BPH patients (in which OAB symptoms remain) who did not respond to alpha-1 blocker monotherapy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Sep 2013
Price :
$35
*
At a glance
- Drugs Imidafenacin (Primary) ; Tamsulosin
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Therapeutic Use
- Acronyms ADDITION
- 14 Aug 2013 Primary endpoint 'Overactive-Bladder-Symptom-Score' has been met according to results published in Urology.
- 14 Aug 2013 Results published in Urology.
- 05 Aug 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.